Bruce Eaton - 02 Mar 2023 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role: EVP, CBO AND CTO
Signature: /s/ Bruce Eaton
Issuer symbol: EDIT
Transactions as of: 02 Mar 2023
Net transactions value: -$898
Form type: 4
Filing time: 06 Mar 2023, 15:30:09 UTC
Previous filing: 15 Feb 2023
Next filing: 11 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDIT	Common Stock	Award	$0	+16,700	+27%	$0.000000	77,683	02 Mar 2023	Direct	F1
transaction	EDIT	Common Stock	Sale	$898	-101	-0.13%	$8.89	77,582	03 Mar 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDIT	Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	02 Mar 2023	Common Stock	50,000	$8.72	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027.
F2	Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2023. The sale does not represent a discretionary trade by the Reporting Person.
F3	This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027.